Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Alexander Yi

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of the American Academy of Dermatology|February 5, 2005
Chronic neuropathic pain associated with imiquimod: report of 2 casesB Alexander Yi, Melissa J Nirenberg, Sanford M Goldstein, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 9, 2004
Evolving potassium channels by means of yeast selection reveals structural elements important for selectivityDelphine Bichet, Yu-Fung Lin, Christian A Ibarra, et al.
The New England Journal of Medicine|July 23, 2021
Abelacimab for Prevention of Venous ThromboembolismPeter Verhamme, B Alexander Yi, Annelise Segers, et al.
Journal of Thrombosis and Haemostasis : JTH|October 29, 2021
Pharmacokinetics and pharmacodynamics of Abelacimab (MAA868), a novel dual inhibitor of Factor XI and Factor XIaB Alexander Yi, Debra Freedholm, Nancy Widener, et al.
Plos One|March 24, 2017
Geometry-dependent functional changes in iPSC-derived cardiomyocytes probed by functional imaging and RNA sequencingChristopher A Werley, Miao-Ping Chien, Jellert Gaublomme, et al.
Cell Research|November 9, 2011
Highly efficient derivation of ventricular cardiomyocytes from induced pluripotent stem cells with a distinct epigenetic signatureHuansheng Xu, B Alexander Yi, Hao Wu, et al.
Lancet (London, England)|May 18, 2025
Safety and efficacy of a novel ANGPTL4 inhibitory antibody for lipid lowering: results from phase 1 and phase 1b/2a clinical studiesBeryl B Cummings, Mark P Joing, Page R Bouchard, et al.
Circulation|August 14, 2025
Human Single-Nucleus RNA Sequencing Identifies CD47 as a Therapeutic Target for Doxorubicin-Induced CardiomyopathyZhen Guo, Anahita Ataran, Pan Ma, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of the American Academy of Dermatology|February 5, 2005
Chronic neuropathic pain associated with imiquimod: report of 2 casesB Alexander Yi, Melissa J Nirenberg, Sanford M Goldstein, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 9, 2004
Evolving potassium channels by means of yeast selection reveals structural elements important for selectivityDelphine Bichet, Yu-Fung Lin, Christian A Ibarra, et al.
The New England Journal of Medicine|July 23, 2021
Abelacimab for Prevention of Venous ThromboembolismPeter Verhamme, B Alexander Yi, Annelise Segers, et al.
Journal of Thrombosis and Haemostasis : JTH|October 29, 2021
Pharmacokinetics and pharmacodynamics of Abelacimab (MAA868), a novel dual inhibitor of Factor XI and Factor XIaB Alexander Yi, Debra Freedholm, Nancy Widener, et al.
Plos One|March 24, 2017
Geometry-dependent functional changes in iPSC-derived cardiomyocytes probed by functional imaging and RNA sequencingChristopher A Werley, Miao-Ping Chien, Jellert Gaublomme, et al.
Cell Research|November 9, 2011
Highly efficient derivation of ventricular cardiomyocytes from induced pluripotent stem cells with a distinct epigenetic signatureHuansheng Xu, B Alexander Yi, Hao Wu, et al.
Lancet (London, England)|May 18, 2025
Safety and efficacy of a novel ANGPTL4 inhibitory antibody for lipid lowering: results from phase 1 and phase 1b/2a clinical studiesBeryl B Cummings, Mark P Joing, Page R Bouchard, et al.
Circulation|August 14, 2025
Human Single-Nucleus RNA Sequencing Identifies CD47 as a Therapeutic Target for Doxorubicin-Induced CardiomyopathyZhen Guo, Anahita Ataran, Pan Ma, et al.
Pageof 2